img

Global Hemangioma Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hemangioma Market Research Report 2024

Hemangioma is the birthmark or benign tumors of infancy that occurs due to an abnormal collection of blood vessels. This occurs in 5-10% of infants worldwide.
According to Mr Accuracy reports new survey, global Hemangioma market is projected to reach US$ 4210.3 million in 2029, increasing from US$ 1925 million in 2022, with the CAGR of 11.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemangioma market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemangioma market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Akrimax
AstraZeneca
Novartis
Cutting Edge Laser Technologies
Pfizer
Pierre Fabre
Segment by Type
Medical Therapy
Laser Therapy
Surgery
Other

Segment by Application


Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hemangioma report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemangioma Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Medical Therapy
1.2.3 Laser Therapy
1.2.4 Surgery
1.2.5 Other
1.3 Market by Application
1.3.1 Global Hemangioma Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemangioma Market Perspective (2018-2029)
2.2 Hemangioma Growth Trends by Region
2.2.1 Global Hemangioma Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hemangioma Historic Market Size by Region (2018-2024)
2.2.3 Hemangioma Forecasted Market Size by Region (2024-2029)
2.3 Hemangioma Market Dynamics
2.3.1 Hemangioma Industry Trends
2.3.2 Hemangioma Market Drivers
2.3.3 Hemangioma Market Challenges
2.3.4 Hemangioma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemangioma Players by Revenue
3.1.1 Global Top Hemangioma Players by Revenue (2018-2024)
3.1.2 Global Hemangioma Revenue Market Share by Players (2018-2024)
3.2 Global Hemangioma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemangioma Revenue
3.4 Global Hemangioma Market Concentration Ratio
3.4.1 Global Hemangioma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemangioma Revenue in 2022
3.5 Hemangioma Key Players Head office and Area Served
3.6 Key Players Hemangioma Product Solution and Service
3.7 Date of Enter into Hemangioma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemangioma Breakdown Data by Type
4.1 Global Hemangioma Historic Market Size by Type (2018-2024)
4.2 Global Hemangioma Forecasted Market Size by Type (2024-2029)
5 Hemangioma Breakdown Data by Application
5.1 Global Hemangioma Historic Market Size by Application (2018-2024)
5.2 Global Hemangioma Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hemangioma Market Size (2018-2029)
6.2 North America Hemangioma Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hemangioma Market Size by Country (2018-2024)
6.4 North America Hemangioma Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemangioma Market Size (2018-2029)
7.2 Europe Hemangioma Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hemangioma Market Size by Country (2018-2024)
7.4 Europe Hemangioma Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemangioma Market Size (2018-2029)
8.2 Asia-Pacific Hemangioma Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hemangioma Market Size by Region (2018-2024)
8.4 Asia-Pacific Hemangioma Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemangioma Market Size (2018-2029)
9.2 Latin America Hemangioma Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hemangioma Market Size by Country (2018-2024)
9.4 Latin America Hemangioma Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemangioma Market Size (2018-2029)
10.2 Middle East & Africa Hemangioma Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hemangioma Market Size by Country (2018-2024)
10.4 Middle East & Africa Hemangioma Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Akrimax
11.1.1 Akrimax Company Detail
11.1.2 Akrimax Business Overview
11.1.3 Akrimax Hemangioma Introduction
11.1.4 Akrimax Revenue in Hemangioma Business (2018-2024)
11.1.5 Akrimax Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemangioma Introduction
11.2.4 AstraZeneca Revenue in Hemangioma Business (2018-2024)
11.2.5 AstraZeneca Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Hemangioma Introduction
11.3.4 Novartis Revenue in Hemangioma Business (2018-2024)
11.3.5 Novartis Recent Development
11.4 Cutting Edge Laser Technologies
11.4.1 Cutting Edge Laser Technologies Company Detail
11.4.2 Cutting Edge Laser Technologies Business Overview
11.4.3 Cutting Edge Laser Technologies Hemangioma Introduction
11.4.4 Cutting Edge Laser Technologies Revenue in Hemangioma Business (2018-2024)
11.4.5 Cutting Edge Laser Technologies Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Hemangioma Introduction
11.5.4 Pfizer Revenue in Hemangioma Business (2018-2024)
11.5.5 Pfizer Recent Development
11.6 Pierre Fabre
11.6.1 Pierre Fabre Company Detail
11.6.2 Pierre Fabre Business Overview
11.6.3 Pierre Fabre Hemangioma Introduction
11.6.4 Pierre Fabre Revenue in Hemangioma Business (2018-2024)
11.6.5 Pierre Fabre Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hemangioma Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Medical Therapy
Table 3. Key Players of Laser Therapy
Table 4. Key Players of Surgery
Table 5. Key Players of Other
Table 6. Global Hemangioma Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Hemangioma Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Hemangioma Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Hemangioma Market Share by Region (2018-2024)
Table 10. Global Hemangioma Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Hemangioma Market Share by Region (2024-2029)
Table 12. Hemangioma Market Trends
Table 13. Hemangioma Market Drivers
Table 14. Hemangioma Market Challenges
Table 15. Hemangioma Market Restraints
Table 16. Global Hemangioma Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Hemangioma Market Share by Players (2018-2024)
Table 18. Global Top Hemangioma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemangioma as of 2022)
Table 19. Ranking of Global Top Hemangioma Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Hemangioma Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemangioma Product Solution and Service
Table 23. Date of Enter into Hemangioma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemangioma Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Hemangioma Revenue Market Share by Type (2018-2024)
Table 27. Global Hemangioma Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Hemangioma Revenue Market Share by Type (2024-2029)
Table 29. Global Hemangioma Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Hemangioma Revenue Market Share by Application (2018-2024)
Table 31. Global Hemangioma Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Hemangioma Revenue Market Share by Application (2024-2029)
Table 33. North America Hemangioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Hemangioma Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Hemangioma Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Hemangioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Hemangioma Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Hemangioma Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Hemangioma Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Hemangioma Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Hemangioma Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Hemangioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Hemangioma Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Hemangioma Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hemangioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Hemangioma Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Hemangioma Market Size by Country (2024-2029) & (US$ Million)
Table 48. Akrimax Company Detail
Table 49. Akrimax Business Overview
Table 50. Akrimax Hemangioma Product
Table 51. Akrimax Revenue in Hemangioma Business (2018-2024) & (US$ Million)
Table 52. Akrimax Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Hemangioma Product
Table 56. AstraZeneca Revenue in Hemangioma Business (2018-2024) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Hemangioma Product
Table 61. Novartis Revenue in Hemangioma Business (2018-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Cutting Edge Laser Technologies Company Detail
Table 64. Cutting Edge Laser Technologies Business Overview
Table 65. Cutting Edge Laser Technologies Hemangioma Product
Table 66. Cutting Edge Laser Technologies Revenue in Hemangioma Business (2018-2024) & (US$ Million)
Table 67. Cutting Edge Laser Technologies Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Hemangioma Product
Table 71. Pfizer Revenue in Hemangioma Business (2018-2024) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Pierre Fabre Company Detail
Table 74. Pierre Fabre Business Overview
Table 75. Pierre Fabre Hemangioma Product
Table 76. Pierre Fabre Revenue in Hemangioma Business (2018-2024) & (US$ Million)
Table 77. Pierre Fabre Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemangioma Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Hemangioma Market Share by Type: 2022 VS 2029
Figure 3. Medical Therapy Features
Figure 4. Laser Therapy Features
Figure 5. Surgery Features
Figure 6. Other Features
Figure 7. Global Hemangioma Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Hemangioma Market Share by Application: 2022 VS 2029
Figure 9. Adult Case Studies
Figure 10. Child Case Studies
Figure 11. Hemangioma Report Years Considered
Figure 12. Global Hemangioma Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Hemangioma Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Hemangioma Market Share by Region: 2022 VS 2029
Figure 15. Global Hemangioma Market Share by Players in 2022
Figure 16. Global Top Hemangioma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemangioma as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Hemangioma Revenue in 2022
Figure 18. North America Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Hemangioma Market Share by Country (2018-2029)
Figure 20. United States Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Hemangioma Market Share by Country (2018-2029)
Figure 24. Germany Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Hemangioma Market Share by Region (2018-2029)
Figure 32. China Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Hemangioma Market Share by Country (2018-2029)
Figure 40. Mexico Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Hemangioma Market Share by Country (2018-2029)
Figure 44. Turkey Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Hemangioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Akrimax Revenue Growth Rate in Hemangioma Business (2018-2024)
Figure 47. AstraZeneca Revenue Growth Rate in Hemangioma Business (2018-2024)
Figure 48. Novartis Revenue Growth Rate in Hemangioma Business (2018-2024)
Figure 49. Cutting Edge Laser Technologies Revenue Growth Rate in Hemangioma Business (2018-2024)
Figure 50. Pfizer Revenue Growth Rate in Hemangioma Business (2018-2024)
Figure 51. Pierre Fabre Revenue Growth Rate in Hemangioma Business (2018-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries